This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Mar:77:62.

doi: 10.1016/j.clinbiochem.2020.01.002. Epub 2020 Jan 16.

P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screening

Clare Fiala¹, Eleftherios P Diamandis²

Affiliations

Affiliations

¹ Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
² Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada. Electronic address: Eleftherios.diamandis@sinaihealth.ca.

PMID: 31954691
DOI: 10.1016/j.clinbiochem.2020.01.002

Comment

P4 medicine or O4 medicine? The perils of population wide, asymptomatic disease screening

Clare Fiala et al. Clin Biochem. 2020 Mar.

. 2020 Mar:77:62.

doi: 10.1016/j.clinbiochem.2020.01.002. Epub 2020 Jan 16.

Authors

Clare Fiala¹, Eleftherios P Diamandis²

Affiliations

¹ Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada.
² Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada; Department of Clinical Biochemistry, University Health Network, Toronto, Ontario, Canada. Electronic address: Eleftherios.diamandis@sinaihealth.ca.

PMID: 31954691
DOI: 10.1016/j.clinbiochem.2020.01.002

No abstract available

PubMed Disclaimer

Comment on

Predictive, personalized, preventive, participatory (P4) cancer medicine.
Hood L, Friend SH. Hood L, et al. Nat Rev Clin Oncol. 2011 Mar;8(3):184-7. doi: 10.1038/nrclinonc.2010.227. Nat Rev Clin Oncol. 2011. PMID: 21364692 Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information